| Literature DB >> 23213303 |
Vishal C Patel1, Daniel K Park, Harry N Herkowitz.
Abstract
Spinal fusion historically has been used extensively, and, recently, the lateral transpsoas approach to the thoracic and lumbar spine has become an increasingly common method to achieve fusion. Recent literature on this approach has elucidated its advantage over more traditional anterior and posterior approaches, which include a smaller tissue dissection, potentially lower blood loss, no need for an access surgeon, and a shorter hospital stay. Indications for the procedure have now expanded to include degenerative disc disease, spinal stenosis, degenerative scoliosis, nonunion, trauma, infection, and low-grade spondylolisthesis. Lateral interbody fusion has a similar if not lower rate of complications compared to traditional anterior and posterior approaches to interbody fusion. However, lateral interbody fusion has unique complications that include transient neurologic symptoms, motor deficits, and neural injuries that range from 1 to 60% in the literature. Additional studies are required to further evaluate and monitor the short- and long-term safety, efficacy, outcomes, and complications of lateral transpsoas procedures.Entities:
Mesh:
Year: 2012 PMID: 23213303 PMCID: PMC3504425 DOI: 10.1100/2012/893608
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Figure 1(a) Preoperative X-rays demonstrating nonunion at L1-2 after posterior instrumented fusion and decompression from L1-S1. (b) Postoperative X-rays demonstrating XLIF at L1-2.
Figure 2Two incision technique for a lateral transpsoas approach. (a) Surgeon's Finger traversing paraspinal muscle incision site, (b) finger identifying the retroperitoneal space, (c) surgeon's finger guiding the first dilator onto the psoas major, and (d) dilator in place traversing the psoas major directly over the intended intervertebral disc space (image reprinted with permission from Nuvasive Inc., San Diego, CA).
Summary of published neurologic XLIF complications.
| Transient neurologic symptoms | Motor deficit | |
|---|---|---|
| Anand et al. [ | 25% | Not recorded |
| Anand et al. [ | 60% | Not recorded |
| Rodgers et al. [ | 1% | Not recorded |
| Knight et al. [ | 9% | 3% |
| Rodgers et al. [ | 1% | Not recorded |
| Isaacs et al. [ | 27% | 33.6% |
| Dakwar et al. [ | 12% | Not recorded |
| Berjano et al. [ | 7% | Not recorded |
| Youssef et al. [ | Not recorded | 1% |